FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

443465002: Ustekinumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2010. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2835090011 Ustekinumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2842331014 Ustekinumab en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ustekinumab Is a Monoclonal antibody agent false Inferred relationship Existential restriction modifier
Ustekinumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ustekinumab 90mg/mL injection solution Has active ingredient False Ustekinumab Inferred relationship Existential restriction modifier
Product containing ustekinumab Has active ingredient True Ustekinumab Inferred relationship Existential restriction modifier 1
Ustekinumab therapy Direct substance True Ustekinumab Inferred relationship Existential restriction modifier 2
Ustekinumab Has active ingredient True Ustekinumab Inferred relationship Existential restriction modifier 1
Product containing precisely ustekinumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Ustekinumab Inferred relationship Existential restriction modifier 1
Product containing precisely ustekinumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Ustekinumab Inferred relationship Existential restriction modifier 1
Product containing only ustekinumab in parenteral dose form (medicinal product form) Has active ingredient True Ustekinumab Inferred relationship Existential restriction modifier 1
Product containing ustekinumab in parenteral dose form (medicinal product form) Has active ingredient True Ustekinumab Inferred relationship Existential restriction modifier 1
Ustekinumab 130mg/26ml solution for infusion vials Has active ingredient False Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection vials Has active ingredient False Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 90mg/1ml solution for injection pre-filled syringes Has active ingredient False Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes Has active ingredient False Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection vials Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Stelara 45mg/0.5ml solution for injection vials (Janssen-Cilag Ltd) Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Stelara 45mg/0.5ml solution for injection vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection vials 1 vial Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Stelara 45mg/0.5ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Stelara 45mg/0.5ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 90mg/1ml solution for injection pre-filled syringes Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Stelara 90mg/1ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 90mg/1ml solution for injection pre-filled syringes 1 pre-filled disposable injection Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Stelara 90mg/1ml solution for injection pre-filled syringes (Janssen-Cilag Ltd) 1 pre-filled disposable injection Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 130mg/26ml solution for infusion vials Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Stelara 130mg/26ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Ustekinumab 130mg/26ml solution for infusion vials 1 vial Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier
Stelara 130mg/26ml concentrate for solution for infusion vials (Janssen-Cilag Ltd) 1 vial Has specific active ingredient True Ustekinumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start